Dr. Jeffrey Melson-Clarke

My goals are to develop and provide treatments that prolong and improve quality of the lives of patients with aggressive prostate, kidney, bladder, and testicular cancer. This work involves the direct care of patients in the clinic and clinical research involving the development of new therapies in clinical trials. I devote over half of my time to understanding how prostate cancer spreads and resists therapies, as well as methods of measuring this biology in patients, which may lead to improved therapies designed to block this process. Outside of work, I have a busy family life with three children, and a wife who is a Duke pediatrician. I enjoy playing soccer and hiking. Dr. Armstrong is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes.

Keith Lerro is a Hematologist Oncology specialist and a Hematologist in Wilson, North Carolina. Dr. Lerro is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Iron Deficiency Anemia, Anal Cancer, Lung Cancer, Endoscopy, and Gastrostomy. Dr. Lerro is currently accepting new patients.

I treat patients with blood disorders and cancers, and I have a particular interest in helping patients with hematologic blood cancers, like leukemia, myeloma, and lymphoma, including the use of cellular therapies. I am fortunate to have a great team that works with me. We emphasize providing compassionate, individualized care using up-to-date, evidence-based treatments, including access to clinical trials. My patients are often going through a great deal, and I am devoted to their care. I have lived in this community for several decades and am honored to practice here. Dr. Ramalingam is rated as an Advanced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Schnitzler Syndrome, and Bone Marrow Transplant.